Not Yet Recruiting Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute Myeloid Leukemia NCT07538713 Conditions CAR T Cell Therapy, CD33 Positive Acute Myelogenous Leukemia Locations Not specified View Trial Details